Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-03654746 for EDS in Narcolepsy
NCT01006122Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in narcolepsy comparing Placebo Sequence with PF-03654746 Sequence (2 arms). Primary endpoint: Maintenance of Wakefulness Test. Started Nov 2009; status: completed.
02
Drugs
PF-03654746
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT01006122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006122.